Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albiglutide Glucose Clamp Study in T2DM
NCT01475734Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2011
- Primary completion
- Jul 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of albiglutide in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Dec 2011; status: completed.
02
Drugs
albiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01475734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475734.